Abbott Laboratories

Dernières actualités

Titres dans la langue d'origine de la source.

• 
  DXCM Report Highlights CGM Growth Opportunity in Type 2 Diabetes Care (s'ouvre dans un nouvel onglet)

  2 oct. 2026

• Nike downgraded, Airbnb upgraded: Wall Street's top analyst calls (s'ouvre dans un nouvel onglet)

  2 oct. 2026

• 
  Here Are Friday’s Top Wall Street Analyst Research Calls: Abbott Laboratories, Airbnb, Cerebras Systems, Coinbase Global, Edison International, Northrop Grumman, Pershing Square, Robinhood Markets, and More (s'ouvre dans un nouvel onglet)

  2 oct. 2026

• 
  4 Low-Beta Healthcare Stocks to Buy Amid Fears of Another Rate Hike (s'ouvre dans un nouvel onglet)

  2 oct. 2026

• Abbott Laboratories stock outperforms competitors despite losses on the day (s'ouvre dans un nouvel onglet)

  MarketWatch · 1 oct. 2026

• Abbott settled a government infant formula lawsuit for nearly $385 million. (s'ouvre dans un nouvel onglet)

  Claim Depot · 1 oct. 2026

• Abbott Laboratories vs. Intuitive Surgical: Which Healthcare Stock Is a Better Buy in 2026? (s'ouvre dans un nouvel onglet)

  The Motley Fool · 1 oct. 2026

• 
  Abbott Stock And Other Healthcare Dividend Names Built For Supply Chain Shocks (s'ouvre dans un nouvel onglet)

  1 oct. 2026

• In 1935, An Illinois Secretary Bought 3 Shares Of Her Company’s Stock For $180. She Never Sold A Single Share And Always Reinvested Dividends. By The Time She Died In 2010 Her 3 Abbott Shares Had Turned Into $7.2 Million. (s'ouvre dans un nouvel onglet)

  1 oct. 2026

• Abbott Laboratories’ Quarterly Earnings Preview: What You Need to Know (s'ouvre dans un nouvel onglet)

  1 oct. 2026

• Analysts Are Bullish on Top Healthcare Stocks: Abbott Laboratories (ABT), Tectonic Therapeutic (TECX) (s'ouvre dans un nouvel onglet)

  The Globe and Mail · 1 oct. 2026

• Biomarkers Market Forecasts Growth from $67.95B (2026) to $112.10B by 2031, Profiling Roche, Abbott, Thermo Fisher & Qiagen (s'ouvre dans un nouvel onglet)

  1 oct. 2026

• Disposable Medical Sensors Market Forecasts Growth from $11.86B (2026) to $16.13B by 2031, Profiling Abbott, Roche, Medtronic & GE HealthCare (s'ouvre dans un nouvel onglet)

  1 oct. 2026

• More Brands Break the US$1 Million Mark as Lazada Celebrates Partner Growth (s'ouvre dans un nouvel onglet)

  1 oct. 2026

• DOJ Announces $385 Million Settlement to Resolve False Claims Allegations over Abbott Laboratories Baby Formula (s'ouvre dans un nouvel onglet)

  MedLearn Publishing · 1 oct. 2026

• Abbott (ABT) Sees a More Significant Dip Than Broader Market: Some Facts to Know (s'ouvre dans un nouvel onglet)

  30 sept. 2026

• Abbott (ABT) Stock May Be 25% Stretched After Biosensor Market Forecast (s'ouvre dans un nouvel onglet)

  Simply Wall Street · 30 sept. 2026

• Abbott Laboratories stock underperforms Wednesday when compared to competitors (s'ouvre dans un nouvel onglet)

  MarketWatch · 30 sept. 2026

• AG Fitch Announces False Claims Settlement with Abbott Laboratories (s'ouvre dans un nouvel onglet)

  MageeNews.com · 30 sept. 2026

• Mississippi to receive more than $771K in $384 million Abbott Laboratories settlement (s'ouvre dans un nouvel onglet)

  Darkhorse Press · 30 sept. 2026

• Abbott Laboratories (ABT) Launches SimpleScreen CRC As Fair Value Stays In Focus (s'ouvre dans un nouvel onglet)

  Yahoo Finance · 30 sept. 2026

• Mississippi to Receive $771K in $384M False Claims Settlement with Abbott Laboratories (s'ouvre dans un nouvel onglet)

  tippahnews.com · 30 sept. 2026

• Abbott launches Freenome’s colorectal cancer screening test (s'ouvre dans un nouvel onglet)

  30 sept. 2026

• Arrow Exploration CEO outlines Colombia growth plan, drilling and M&A - One2One Investor Forum (s'ouvre dans un nouvel onglet)

  30 sept. 2026

• Mississippi receives $771K in Abbott formula settlement (s'ouvre dans un nouvel onglet)

  WJTV · 30 sept. 2026

• Abbott hosts conference call for third-quarter earnings (s'ouvre dans un nouvel onglet)

  30 sept. 2026

• Abbott Laboratories (NYSE:ABT): Are Investors Getting Over Their Scepticism Over The Company's Bold US$21bn Bet On Exact Sciences? (s'ouvre dans un nouvel onglet)

  Stocks Down Under · 29 sept. 2026

• Beta Bionics Stock Down Despite iLet-Eversense 365 Integration Deal (s'ouvre dans un nouvel onglet)

  Zacks · 29 sept. 2026

• 3 Historically Stable Dividend Raisers in Medical Devices Offering Solid Yields With Fortress-Like Growth (s'ouvre dans un nouvel onglet)

  24/7 Wall St. · 29 sept. 2026

• How Big Could BSX Stock's Next Fall Be? (s'ouvre dans un nouvel onglet)

  Trefis · 28 sept. 2026